The skin cancer diagnostics market is projected to reach US$ US$ 5,480.45 million by 2028 from US$ 3,364.46 million in 2021; it is estimated to grow at a CAGR of 7.2% during 2021-2028. The report highlights trends prevailing in the market and factors driving its growth. The market's growth is attributed to the increasing incidence of skin cancer and launch of new products. However, the barriers to early skin cancer diagnostics in low and middle-income countries hampers the market growth.
The surge in awareness is primarily attributed to the support provided by various governments through awareness and prevention campaigns. The Centers for Disease Control and Prevention (CDC) and its partners conduct monitoring of skin cancer cases, their research, provide education, and interventions for skin cancer. The monitoring is achieved through national surveys - such as the Youth Risk Behavior Surveillance System and National Health Interview Survey. These surveys assist in assessing the prevalence of sunburn and sun-protective behaviors to help prevent skin cancer. Countries such as the UK and the Netherlands have also taken initiatives for promoting the early diagnosis of skin cancer. In 2007, the Early Diagnostics Program was initiated at Cancer Research UK, as part of the National Awareness and Early Diagnosis Initiative (NAEDI) for England. Similarly, in July 2011, the Skin Cancer Prevention Strategy and Action Plan (2011-2021) was launched in Northern Ireland, with a major focus on the prevention and early detection of skin cancer in the region. Thus, governments’ efforts to control mortalities associated with skin cancer are likely to provide significant opportunities to the skin cancer diagnostics market players in the coming years.
Based on type, the global skin cancer diagnostics market has been segmented into melanoma and non-melanoma. The non-melanoma segment held the largest share of the market in 2021 and is anticipated to register highest CAGR in the market during the forecast period. Based on screening type, the market is segmented into blood tests, dermatoscopy, imaging tests, lymph node biopsy, and skin biopsy. The skin biopsy segment held the largest share of the market in 2021 and is anticipated to register a high CAGR in the market during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the skin cancer diagnostics market are the National Center for Health Statistics, Indian Council of Medical Research, Centers for Disease Control and Prevention (CDC), the National Center for Biotechnology Information (NCBI), and World Health Organization.
Reasons to Buy
The surge in awareness is primarily attributed to the support provided by various governments through awareness and prevention campaigns. The Centers for Disease Control and Prevention (CDC) and its partners conduct monitoring of skin cancer cases, their research, provide education, and interventions for skin cancer. The monitoring is achieved through national surveys - such as the Youth Risk Behavior Surveillance System and National Health Interview Survey. These surveys assist in assessing the prevalence of sunburn and sun-protective behaviors to help prevent skin cancer. Countries such as the UK and the Netherlands have also taken initiatives for promoting the early diagnosis of skin cancer. In 2007, the Early Diagnostics Program was initiated at Cancer Research UK, as part of the National Awareness and Early Diagnosis Initiative (NAEDI) for England. Similarly, in July 2011, the Skin Cancer Prevention Strategy and Action Plan (2011-2021) was launched in Northern Ireland, with a major focus on the prevention and early detection of skin cancer in the region. Thus, governments’ efforts to control mortalities associated with skin cancer are likely to provide significant opportunities to the skin cancer diagnostics market players in the coming years.
Based on type, the global skin cancer diagnostics market has been segmented into melanoma and non-melanoma. The non-melanoma segment held the largest share of the market in 2021 and is anticipated to register highest CAGR in the market during the forecast period. Based on screening type, the market is segmented into blood tests, dermatoscopy, imaging tests, lymph node biopsy, and skin biopsy. The skin biopsy segment held the largest share of the market in 2021 and is anticipated to register a high CAGR in the market during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the skin cancer diagnostics market are the National Center for Health Statistics, Indian Council of Medical Research, Centers for Disease Control and Prevention (CDC), the National Center for Biotechnology Information (NCBI), and World Health Organization.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global skin cancer diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global skin cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Skin Cancer Diagnostics Market - By Type
1.3.2 Global Skin Cancer Diagnostics Market - By Screening Type
1.3.3 Global Skin Cancer Diagnostics Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Skin Cancer Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America - PEST Analysis
4.3 Expert Opinion
5. Skin Cancer Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Skin Cancer
5.1.2 Launch of New Products
5.2 Market Restraints
5.2.1 Barriers to Early Skin Cancer Diagnostics in Low and Middle-Income Countries
5.3 Market Opportunities
5.3.1 Government Support for Early Skin Cancer Diagnosis
5.4 Future Trends
5.4.1 Skin Cancer Diagnostics Through AI
5.5 Impact Analysis
6. Skin Cancer Diagnostics Market - Global Analysis
6.1 Global Skin Cancer Diagnostics Market Revenue Forecast and Analysis
6.2 Global Skin Cancer Diagnostics Market Revenue Forecast and Analysis
6.3 Market Positioning of Key Players
7. Skin Cancer Diagnostics Market Analysis - By Type
7.1 Overview
7.2 Skin Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
7.3 Melanoma
7.3.1 Overview
7.3.2 Melanoma: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Non-melanoma
7.4.1 Overview
7.4.2 Non-melanoma: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8. Skin Cancer Diagnostics Market - By Screening Type
8.1 Overview
8.2 Skin Cancer Diagnostics Market, by Screening Type, 2021 and 2028 (%)
8.3 Blood Tests
8.3.1 Overview
8.3.2 Blood Tests: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Dermatoscopy
8.4.1 Overview
8.4.2 Dermatoscopy: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Imaging Tests
8.5.1 Overview
8.5.2 Imaging Tests: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Lymph Node Biopsy
8.6.1 Overview
8.6.2 Lymph Node Biopsy: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Skin Biopsy
8.7.1 Overview
8.7.2 Skin Biopsy: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9. Skin Cancer Diagnostics Market - Regional Analysis
9.1 North America: Skin Cancer Diagnostics Market
9.1.1 Overview
9.1.2 North America: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.1.3 North America: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.1.4 North America: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ Million)
9.1.5 North America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.1.1 US: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.1.2 US: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.1.5.1.3 US: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ ‘Million)
9.1.5.2 Canada: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.2.1 Canada: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.2.2 Canada: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.1.5.2.3 Canada: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ ‘Million)
9.1.5.3 Mexico: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.3.1 Mexico: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.3.2 Mexico: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.1.5.3.3 Mexico: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ ‘Million)
9.2 Europe: Skin Cancer Diagnostics Market
9.2.1 Overview
9.2.2 Europe: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.2.4 Europe: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.2.5 Europe: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.2.5.1 Germany: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Overview
9.2.5.1.2 Germany: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 Germany: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.2.5.1.4 Germany: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.2.5.2 United Kingdom: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 Overview
9.2.5.2.2 United Kingdom: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.3 United Kingdom: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.2.5.2.4 United Kingdom: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.2.5.3 France: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 Overview
9.2.5.3.2 France: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.3 France: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.2.5.3.4 France: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.2.5.4 Italy: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Overview
9.2.5.4.2 Italy: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.3 Italy: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.2.5.4.4 Italy: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.2.5.5 Spain: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Overview
9.2.5.5.2 Spain: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.3 Spain: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.2.5.5.4 Spain: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.2.5.6 Rest of Europe: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Overview
9.2.5.6.2 Rest of Europe: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.2.5.6.4 Rest of Europe: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.3 Asia Pacific Skin Cancer Diagnostics Market Revenue and Forecasts To 2028
9.3.1 Overview
9.3.2 Asia-Pacific: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia-Pacific: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.3.4 Asia-Pacific: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.3.5 Asia-Pacific: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.3.5.1 China: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.1 Overview
9.3.5.1.2 China: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ MILLION)
9.3.5.1.3 China: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.3.5.1.4 China: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.3.5.2 Japan: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ MILLION)
9.3.5.2.1 Overview
9.3.5.2.2 Japan: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.3 Japan: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.3.5.2.4 Japan: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.3.5.3 India: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.1 Overview
9.3.5.3.2 India: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.3 India: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.3.5.3.4 India: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.3.5.4 South Korea: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.1 Overview
9.3.5.4.2 South Korea: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.3 South Korea: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.3.5.4.4 South Korea: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.3.5.5 Australia: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.1 Overview
9.3.5.5.2 Australia: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.3 Australia: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.3.5.5.4 Australia: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.3.5.6 Rest of Asia-Pacific: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 Overview
9.3.5.6.2 Rest of Asia-Pacific: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.3 Rest of Asia-Pacific: Skin Cancer Diagnostics Market, by Type - 2019-2028 (US$ Million)
9.3.5.6.4 Rest of Asia-Pacific: Skin Cancer Diagnostics Market, by Screening Type - 2019-2028 (US$ Million)
9.4 Middle East and Africa: Skin Cancer Diagnostics Market
9.4.1 Overview
9.4.2 Middle East and Africa: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.4.3 Middle East and Africa: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.4.4 Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ Million)
9.4.5 Middle East and Africa: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.4.5.1 UAE: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.1.1 UAE: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.1.2 UAE: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.4.5.1.3 UAE: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ ‘Million)
9.4.5.2 Saudi Arabia: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.2.1 Saudi Arabia: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.2.2 Saudi Arabia: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.4.5.2.3 Saudi Arabia: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ ‘Million)
9.4.5.3 South Africa: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.3.1 South Africa: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.3.2 South Africa: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.4.5.3.3 South Africa: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ ‘Million)
9.4.5.4 Rest of Middle East and Africa: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.4.1 Rest of Middle East and Africa: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.4.2 Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.4.5.4.3 Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ ‘Million)
9.5 South and Central America: Skin Cancer Diagnostics Market
9.5.1 Overview
9.5.2 South and Central America: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.5.3 South and Central America: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.5.4 South and Central America: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ Million)
9.5.5 South and Central America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.5.5.1 Brazil: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.1.1 Brazil: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.1.2 Brazil: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.5.5.1.3 Brazil: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ ‘Million)
9.5.5.2 Argentina: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.2.1 Argentina: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.2.2 Argentina: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.5.5.2.3 Argentina: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ ‘Million)
9.5.5.3 Rest of South and Central America: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.3.1 Rest of South and Central America: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.3.2 Rest of South and Central America: Skin Cancer Diagnostics Market, by Type, 2019-2028 (US$ ‘Million)
9.5.5.3.3 Rest of South and Central America: Skin Cancer Diagnostics Market, by Screening Type, 2019-2028 (US$ ‘Million)
10. Impact of COVID-19 Pandemic on Global Skin Cancer Diagnostics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Skin Cancer Diagnostic Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Skin Cancer Diagnostic Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 SkylineDx BV
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 SWOT Analysis
12.1.5 Key Developments
12.2 AMLo Biosciences Limited
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 SWOT Analysis
12.2.5 Key Developments
12.3 NeraCare GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 SWOT Analysis
12.3.5 Key Developments
12.4 DermLite LLC
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 bioMerieux SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Veriskin Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Castle Biosciences, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DermTech Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 HOFFMANN-LA ROCHE LTD.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.10 Michelson Diagnostics Ltd.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Publisher
13.2 Glossary of Terms List of Tables
Table 1. North America: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 2. North America: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. US: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 4. US: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. Canada: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. Canada: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Mexico: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Mexico: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Europe Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. Europe Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 11. Germany Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. United Kingdom Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. United Kingdom Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 15. France Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 16. France Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 23. Asia-Pacific Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 24. Asia-Pacific Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 25. China Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 26. China Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 27. Japan Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 28. Japan Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 29. India Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 30. India Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 31. South Korea Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 32. South Korea Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 33. Australia Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 34. Australia Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Asia-Pacific Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Asia-Pacific Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 37. Middle East and Africa: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 38. Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 39. UAE: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 40. UAE: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 41. Saudi Arabia: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 42. Saudi Arabia: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 43. South Africa: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 44. South Africa: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 45. Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 46. Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 47. South and Central America: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 48. South and Central America: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ Million)
Table 49. Brazil: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 50. Brazil: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 51. Argentina: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 52. Argentina: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 53. Rest of South and Central America: Skin Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 54. Rest of South and Central America: Skin Cancer Diagnostics Market, by Screening Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 1. Organic Developments in the Skin Cancer Diagnostic Market
Table 2. Inorganic Developments in the Skin Cancer Diagnostics Market
Table 3. Glossary of Terms, Skin Cancer Diagnostics Market
Table 4. Acronym
List of Figures
Figure 1. Skin Cancer Diagnostics Market Segmentation
Figure 2. Skin Cancer Diagnostics Market, By Region
Figure 3. Global Skin Cancer Diagnostics Market Overview
Figure 4. Non-Melanoma Segment Held Largest Share of Type Segment in Skin Cancer Diagnostics Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Skin Cancer Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Skin Cancer Diagnostics Market- Leading Country Markets (US$ Million)
Figure 8. Global Skin Cancer Diagnostics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Skin Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 15. Global Skin Cancer Diagnostics Market - Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global Skin Cancer Diagnostics Market - Revenue Forecast and Analysis - 2021 - 2028
Figure 17. Market Positioning of Key Players in Global Skin Cancer Diagnostics Market
Figure 18. Skin Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
Figure 19. Melanoma: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Non-melanoma: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Skin Cancer Diagnostics Market, by Screening Type, 2021 and 2028 (%)
Figure 22. Blood Tests: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Dermatoscopy: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Imaging Tests: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Lymph Node Biopsy: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Skin Biopsy: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America: Skin Cancer Diagnostics Market, by Key Country - Revenue (2021) (US$ ‘Million)
Figure 28. North America: Skin Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 29. North America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 30. US: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 31. Canada: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 32. Mexico: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 33. Europe: Skin Cancer Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 34. Europe Skin Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. Europe: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 36. Germany: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. United Kingdom: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. France: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Italy: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Spain: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Rest of Europe: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Asia-Pacific: Skin Cancer Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 43. Asia-Pacific Skin Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 44. Asia-Pacific: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 45. China: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ MILLION)
Figure 46. Japan: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. India: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. South Korea: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Australia: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Rest of Asia-Pacific: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Middle East and Africa: Skin Cancer Diagnostics Market, by Key Country - Revenue (2021) (US$ ‘Million)
Figure 52. Middle East and Africa: Skin Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 53. Middle East and Africa: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 54. UAE: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 55. Saudi Arabia: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 56. South Africa: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 57. Rest of Middle East and Africa: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 58. South and Central America: Skin Cancer Diagnostics Market, by Key Country - Revenue (2021) (US$ ‘Million)
Figure 59. South and Central America: Skin Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 60. South and Central America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 61. Brazil: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 62. Argentina: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 63. Rest of South and Central America: Skin Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 64. Impact Of COVID-19 Pandemic in North American Country Markets
Figure 65. Impact of COVID-19 Pandemic in European Country Markets
Figure 66. Impact of COVID-19 Pandemic in Asia Pacific Countries
Figure 67. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 68. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 69. Growth Strategies in the Skin Cancer Diagnostic Market (%) 1
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- SkylineDx BV
- AMLo Biosciences Limited
- NeraCare GmbH
- DermLite LLC
- bioMerieux SA
- Veriskin Inc.
- Castle Biosciences, Inc.
- DermTech Inc.
- HOFFMANN-LA ROCHE LTD.
- Michelson Diagnostics Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 197 |
| Published | February 2022 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 3364.46 million |
| Forecasted Market Value ( USD | $ 5480.45 million |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
